Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant
Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions
What You Should Know:
- New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”).
- Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics.
- Velsera, headquartered in
Read More
17 Executive Hospital/Health System Predictions to Watch in 2023
Vijay Kedar, Co-Founder and CEO at Tomorrow Health
Health systems will realize their challenges are not transitory but systemic: This year saw health systems facing a myriad of compounding threats – from historic inflation exacerbating their cost structures, front-line clinician burnout driving widespread labor shortages, and increased capacity issues that left patients in hospital facilities one full day longer than in the prior year. As the financial markets turned south, many institutions
Read More
Caris Life Sciences and ConcertAI Partner to Accelerate Drug Development and Novel Research
What You Should Know:
- Caris Life Sciences®(Caris), a molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, an oncology real-world evidence data and AI technology company, announced a unique partnership to align the two companies' oncology capabilities.
- The strategic partnership will create one of the largest translational and clinical
Read More
Real-World Data Startup Crescendo Health Launches with $3.2M
What You Should Know:
- Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations.
- Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More
C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
What You Should Know:
- C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.
- The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers.
- Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
Why The Future of Lateral Flow Testing is Digital
Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’ (Dx) practice, as well as a growing range of applications outside healthcare. LFT's capacity for delivering fast turnaround—rapid detection in less than 20 minutes—from sample to result has made LFTs central to the shift moving triage and primary care closer to the patient at point-of-care (POC) and point-of-need (PON).
Being intuitive for the user,
Read More
Modernizing Data Access: 3 Tips for Securing Patient Data in the Cloud
There is a tremendous amount of data within the healthcare and life sciences industries. According to RBC Capital Markets, the healthcare sector accounts for 30% of the world’s data and is forecasted to grow by a compound annual growth rate of 36% in the next two and half years.
The benefit is that healthcare professionals, organizations, and analysts can use this data to improve the quality, quantity, and accessibility of healthcare. But it also carries great risk. More organizations
Read More
Can Doctors Objectively Quantify and Measure Pain?
Millions of Americans live with acute and chronic pain that affects every aspect of their lives. Pain by itself is an important marker of how a patient is feeling and indicates what kind of medical intervention might be necessary. The healthcare industry needs a clinically acceptable way to objectively measure pain and since pain is a very complex mixture of biochemistry and genetics and it’s unlikely that a laboratory test that directly quantifies pain will be developed.
Doctors
Read More
2022 Telemental Health Regulations Unlock Access and Evolve Compliance Practices
What You Should Know:
- Epstein Becker Green (EBG) recently released its 2022 updates to the Telemental Health Laws survey.
- The 2022 updates report a significant evolution of the telemental health and telehealth industries, including increased regulatory flexibilities that promote increased use of telehealth.
Insights and Trends from Telemental Health’s Survey
The Telemental Health Laws survey is authored by Amy Lerman and Audrey Davis, with support from Jenna Horowitz, Erin
Read More
